The US State of Pennsylvania has given a grant of $300,000 to help advance the clinical testing of opaganib from Israel’s RedHill Biopharma (reported here previously). The grant is part of the state’s program supporting the rapid advancement of promising novel COVID-19 therapies.
Pennsylvania grant for Covid-19 therapy
This entry was posted in Economy & Business. Bookmark the permalink.